Cover
Cover - USD ($) | 12 Months Ended | ||
Oct. 31, 2023 | Jan. 24, 2024 | Apr. 30, 2023 | |
Cover [Abstract] | |||
Entity Registrant Name | Pharma-Bio Serv, Inc. | ||
Entity Central Index Key | 0001304161 | ||
Document Type | 10-K/A | ||
Amendment Flag | true | ||
Entity Voluntary Filers | No | ||
Current Fiscal Year End Date | --10-31 | ||
Entity Well Known Seasoned Issuer | No | ||
Entity Small Business | true | ||
Entity Shell Company | false | ||
Entity Emerging Growth Company | false | ||
Entity Current Reporting Status | Yes | ||
Document Period End Date | Oct. 31, 2023 | ||
Entity Filer Category | Non-accelerated Filer | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2023 | ||
Entity Common Stock Shares Outstanding | 22,963,143 | ||
Entity Public Float | $ 13,638,206 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Fin Stmt Error Correction Flag | false | ||
Entity File Number | 0-50956 | ||
Entity Incorporation State Country Code | DE | ||
Entity Tax Identification Number | 20-0653570 | ||
Entity Address Address Line 1 | Pharma-Bio Serv Building | ||
Entity Address Address Line 2 | #6 Road 696 | ||
Entity Address City Or Town | Dorado | ||
Entity Address Country | PR | ||
Entity Address Postal Zip Code | 00646 | ||
City Area Code | 787 | ||
Amendment Description | This Form 10-K/A (“Amendment No. 1”) amends the annual report on Form 10-K of Pharma-Bio Serv, Inc. (the “Company”) for the fiscal year ended October 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on January 29, 2024 (the “2023 Form 10-K”). The primary purpose of Amendment No. 1 is to provide the information required by Items 10 through 14 of Part III of the 2023 Form 10-K. | ||
Icfr Auditor Attestation Flag | false | ||
Auditor Name | Pedro J. Lasanta | ||
Auditor Location | Guaynabo, Puerto Rico | ||
Auditor Firm Id | 871 | ||
Local Phone Number | 278-2709 | ||
Entity Interactive Data Current | Yes |